Search
Menu
Home
HTB
2019
December
HTB
December 2019
Contents
Editorial
i-Base 2019 appeal: we need your help….
HTB 13 December 2019 online
Supplements
Introduction to ART – October 2019
UK Guide to PrEP – November 2019
Conference reports
17th European AIDS Conference (EACS 2019)
Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV
Dolutegravir/lamivudine as dual ART
Weight changes with doravirine-based first line therapy
Bone and renal changes in the ADVANCE trial
10th International Workshop on HIV and Ageing
Impact of isolation and loneliness on older people living with HIV
Antiretrovirals
Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF
Fostemsavir submitted to US FDA for multidrug resistant HIV
Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA
Lipodystrophy and metabolic complications
Tesamorelin for NAFLD in people living with HIV
PDFs
13 December 2019 vol 20 no 14
HTB RSS
Early access
In-utero tenofovir-based PrEP has no effect on children’s bone mineral density
25 September 2023
>10% weight gain during first two years of ART linked to double the risk of cardiometabolic disease
25 September 2023
Mutations associated with resistance to dapivirine vaginal ring: reported in 7/38 women seroconverting in the open-label HOPE study
25 September 2023
Early phase 1 HIV vaccine study launched in the US and South Africa
21 September 2023
All early access reports
Current issues
September 2023
August 2023
June 2023
Back issues
Special report
Latest statistics on HIV in the UK: data for 2021
1 December 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage